Floatz logo

3-N-BUTYLPHTHALIDE

Large-artery Occlusion

The Second Hospital of Hebei Medical UniversitySmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Large-artery Occlusion cohort.

Asset / SponsorPhaseRating
Recombinant Human Plasminogen Activator
The First Affiliated Hospital with Nanjing Medical University
Phase 3B
Recombinant Human Plasminogen Activator
The First Affiliated Hospital with Nanjing Medical University
Phase 3B
Tenecteplase
Beijing Tiantan Hospital
Phase 3B
WARFARIN
Columbia University
Phase 3B
ROPIVACAINE
University of Sao Paulo General Hospital
Phase 3B

View all 10 →

Same molecule, other indications

3-N-BUTYLPHTHALIDE is also rated in:

ischemic strokeDormant
BBB
Indicative ·
72 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
72 / 100
View asset →
Collateral CirculationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →